|
|
||||||||
RESEARCH COMMUNICATION |
a Département d'Immunologie, Institut Pasteur, 75015 Paris, France
b Unité d'Immunologie Transfusionelle, INTS, 75015 Paris, France
HIV infection is characterized by accelerated apoptosis and progressive loss of B cells. To see whether these abnormalities are related to the property of gp120 to act as a superantigen for VH3+ B cells, we probed the temporal development of VH3+ antibodies in HIV-1-infected subjects over a 7-year period. We found that VH3+ antibodies specific for the gp120 superantigen binding site are deficient. Since VH3+ antibodies impart protective responses to infectious agents, we quantified VH3+ antibodies in serum samples from HIV-seropositive slow progressors and from patients who progressed to AIDS-related manifestations. We found that paucity in VH3+ antibodies is a marker of rapid clinical decline. Remarkably, anti-gp160 VH3+ antibodies showed a gradual decrease in progressors and, with time, varied depending on the viral load. We conclude that disease aggravation is associated with a decrease of the magnitude of the humoral response, that VH3+ antibodies play an important role in protection, and that their underexpression may accelerate disease progression. We propose that vaccine preparations able to trigger VH3+ antibodies might confer a better protection against HIV infection. This work also represents a novel mechanism of humoral deficiency resulting from the capacity of a viral antigen to affect an important subset of the B cell repertoire and to induce B cell death by apoptosis.Juompan, L., Lambin, P., Zouali, M. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J. 12, 14731480 (1998)
Key Words: B cell death immunoglobulin isotypes disease progression
This article has been cited by other articles:
![]() |
D. Capello, M. Martini, A. Gloghini, M. Cerri, S. Rasi, C. Deambrogi, D. Rossi, M. Spina, U. Tirelli, L. M. Larocca, et al. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis Haematologica, August 1, 2008; 93(8): 1178 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viau, N. S. Longo, P. E. Lipsky, and M. Zouali Staphylococcal Protein A Deletes B-1a and Marginal Zone B Lymphocytes Expressing Human Immunoglobulins: An Immune Evasion Mechanism J. Immunol., December 1, 2005; 175(11): 7719 - 7727. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas, Y. Nishiyama, B. Handy, R. Hunter, A. Edmundson, and C. Hanson Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120 J. Biol. Chem., September 17, 2004; 279(38): 39611 - 39619. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viau, N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L Infect. Immun., June 1, 2004; 72(6): 3515 - 3523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Hewson, J. J. Logie, P. Simmonds, and S. E. M. Howie A CCR5-Dependent Novel Mechanism for Type 1 HIV gp120 Induced Loss of Macrophage Cell Surface CD4 J. Immunol., April 15, 2001; 166(8): 4835 - 4842. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells J. Immunol., May 15, 2000; 164(10): 5482 - 5491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |